tirzepatide regulatory filings approved for weight loss Eli Lilly eyes tirzepatide cardio

Emerging research suggests GLP-1 receptor agonists may also influence inflammatory pathways indirectly through metabolic improvements

The FDA-approved prescribing information for metoclopramide includes gastroparesis as an indication at doses of 10-15 mg taken 30 minutes before each meal and at bedtime

From its powerful antioxidant properties to its gentle approach to skin brightening, it addresses multiple skin concerns without the harsh side effects of traditional treatments

For example, one study showed that although people treated for 68 weeks with semaglutide (2.4 mg/week) lost an average of 18% of their initial body weight, the majority of this weight was regained within a year following discontinuation of treatment (Figure 7)